Vicarious Surgical (RBOT) Total Debt (2021 - 2022)
Vicarious Surgical (RBOT) reported Total Debt of $850000.0 for Q3 2022, down 40.81% year-over-year from $1.4 million in Q3 2021, and down 14.31% on a QoQ basis from $992000.0 in Q2 2022.
Vicarious Surgical (RBOT) has 2 years of Total Debt data on file, last reported at $850000.0 in Q3 2022.
- Quarterly Total Debt fell 40.81% year-over-year to $850000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $850000.0 (down 40.81% YoY) and the FY2021 annual result came in at $1.3 million, changed N/A from the prior year.
- Total Debt eased to $850000.0 in Q3 2022 per RBOT's latest filing, from $992000.0 in the prior quarter.
- Across five years, Total Debt topped out at $1.4 million in Q3 2021 and bottomed at $850000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.93 Bn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 850,000.00 |
| Jun 30, 2022 | 992,000.00 |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 1.28 Mn |
| Sep 30, 2021 | 1.44 Mn |